BiotechTube
Home/Luxa Biotechnology/Keith E. Dionne, Ph.D.
KE

Keith E. Dionne, Ph.D.

Chief Executive Officer

Luxa Biotechnology

Therapeutic Areas

OphthalmologyRetinal Diseases

Luxa Biotechnology Pipeline

DrugIndicationPhase
RPESC-RPE-4WDry Age-Related Macular Degeneration (AMD) / Geographic AtrophyPhase 1/2a

Leadership Team at Luxa Biotechnology

ST
Sally Temple, Ph.D.
Founder, Chief Scientific Officer
JS
Jeffrey Stern, Ph.D., M.D.
Founder, Chief Medical Officer
EO
Eric Oh
Founder, Co-CEO
View full Luxa Biotechnology profile